Search - tctmd.com

Displaying 341 - 360 of 815

Sort: Relevancy | Date

News Daily News

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

L.A. McKeown

September 14, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Todd Neale

August 26, 2018

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Todd Neale

August 01, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Opinion Fellow Talk

Navigating Vascular Access as a Cardiology Fellow

Udit Bhatnagar, MD

July 12, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Conference News EuroPCR 2018

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Michael O'Riordan

May 29, 2018

News CV Team Pro

Featured Cath Lab Pro: Marian Hawkey

May 20, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Daily News

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

L.A. McKeown

April 12, 2018

News Daily News

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Yael L. Maxwell

April 10, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

Advertisement

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Hospital Readmissions at 30 Days Declining for Stroke Patients

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Navigating Vascular Access as a Cardiology Fellow

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Featured Cath Lab Pro: Marian Hawkey

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content